Treatment for lupus, first in 50 years, offers modest benefits, hope to patients

JAMA. 2011 May 4;305(17):1754-5. doi: 10.1001/jama.2011.548.
No abstract available

Publication types

  • News

MeSH terms

  • African Americans
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials as Topic
  • Drug Approval*
  • Drug Costs
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / ethnology
  • United States
  • United States Food and Drug Administration

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • belimumab